aap Implantate AG (AAQ1) - Total Assets
Based on the latest financial reports, aap Implantate AG (AAQ1) holds total assets worth €13.98 Million EUR (≈ $16.35 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See debt-free asset ratio of aap Implantate AG to measure how much of total assets are equity-financed.
aap Implantate AG - Total Assets Trend (2016–2024)
This chart illustrates how aap Implantate AG's total assets have evolved over time, based on quarterly financial data. Check AAQ1 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
aap Implantate AG - Asset Composition Analysis
Current Asset Composition (December 2024)
aap Implantate AG's total assets of €13.98 Million consist of 56.1% current assets and 43.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 13.1% |
| Accounts Receivable | €1.95 Million | 12.3% |
| Inventory | €4.09 Million | 25.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.88 Million | 11.9% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how aap Implantate AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see AAQ1 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: aap Implantate AG's current assets represent 56.1% of total assets in 2024, a decrease from 65.4% in 2016.
- Cash Position: Cash and equivalents constituted 13.1% of total assets in 2024, down from 37.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 17.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 25.8% of total assets.
aap Implantate AG Competitors by Total Assets
Key competitors of aap Implantate AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
aap Implantate AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.40 | 2.12 | 2.01 |
| Quick Ratio | 1.24 | 1.03 | 0.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €4.51 Million | €4.76 Million | €4.84 Million |
aap Implantate AG - Advanced Valuation Insights
This section examines the relationship between aap Implantate AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.33 |
| Latest Market Cap to Assets Ratio | 1.93 |
| Asset Growth Rate (YoY) | -8.4% |
| Total Assets | €15.84 Million |
| Market Capitalization | $30.63 Million USD |
Valuation Analysis
Above Book Valuation: The market values aap Implantate AG's assets above their book value (1.93x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: aap Implantate AG's assets decreased by 8.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for aap Implantate AG (2016–2024)
The table below shows the annual total assets of aap Implantate AG from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €15.84 Million ≈ $18.52 Million |
-8.36% |
| 2023-12-31 | €17.28 Million ≈ $20.20 Million |
-14.56% |
| 2022-12-31 | €20.23 Million ≈ $23.65 Million |
-11.88% |
| 2021-12-31 | €22.95 Million ≈ $26.84 Million |
+16.48% |
| 2020-12-31 | €19.71 Million ≈ $23.04 Million |
-25.04% |
| 2019-12-31 | €26.29 Million ≈ $30.73 Million |
-37.74% |
| 2018-12-31 | €42.22 Million ≈ $49.36 Million |
-16.34% |
| 2017-12-31 | €50.47 Million ≈ $59.00 Million |
-20.96% |
| 2016-12-31 | €63.85 Million ≈ $74.65 Million |
-- |
About aap Implantate AG
aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials. The company sells its products directly to hospitals, purchasing groups, and hospital… Read more